PIONEER 2 (n=816) demonstrated Rybelsus achieved superior A1C reductions of 1.4-1.5% compared to comparator medications
190 One study further explored the downstream consequences of this co-localization and demonstrated for the first time that cytoplasmic CTSB, rather than trypsin, initiates acinar cell death in AP
A new prescription and a new prior authorization are required when you switch from one covered GLP-1 medication to another
Russo GL, Vastolo V, Ciccarelli M, Albano L, Macchia PE, Ungaro P
Collaborative care involving GPs, diabetes specialist nurses, and dietitians optimises outcomes and minimises potential complications
Journal of Molecular Liquids